Back to Trades
LaPlume Joseph W
EVPCorp Strategy & DevelopCIK 0001767215
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2025–2026
LaPlume Joseph W, EVP, Corp Strategy & Develop, has filed 6 SEC reports (2025–2026), all concentrated in CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), totaling $1.4M in disclosed volume. Weighing $0 bought versus $251.6K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Aug 11 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | LaPlume Joseph W | EVP, Corp Strategy & Develop | Gift | $0 |
| Jun 2 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | LaPlume Joseph W | EVP, Corp Strategy & Develop | Grant | $950.0K |
| May 28 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | LaPlume Joseph W | EVP, Corp Strategy & Develop | Tax withheld | $67.9K |
| Jan 20 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | LaPlume Joseph W | EVP, Corp Strategy & Develop | Sell | $65.5K |
| Aug 20 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | LaPlume Joseph W | EVP, Corp Strategy & Develop | Sell | $126.1K |
| Aug 8 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | LaPlume Joseph W | EVP, Corp Strategy & Develop | Sell | $60.0K |
6 filings